Patents by Inventor Jin Hee Eum

Jin Hee Eum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12091679
    Abstract: Provided are a storage method and a banking system of cells prepared using somatic cell nuclear transfer (NT) technology with homozygous genotypes of genes of human leukocyte antigen (HLA)-A, HLA-B, HLA-DR, and the like. The banking of NT cell-derived stem cells may be applied to autologous or allogenic patients and can provide transplantable cells and tissue materials for the treatment of various diseases such as diabetes, osteoarthritis, Parkinson's disease, and the like.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: September 17, 2024
    Assignees: SUNGKWANG MEDICAL FOUNDATION, CHA BIOTECH CO., LTD.
    Inventors: Kwang Yul Cha, Dong Ryul Lee, Young Gie Chung, Jihwan Song, Jin Hee Eum
  • Patent number: 11535824
    Abstract: The present invention provides methods and compostions to improve the efficiency of somatic cell nuclear transfer (SCNT). There is increasing evidence that the epigenetic state of donor nuclei has a significant impact on potential of nuclear transfer embryos to develop into blastocysts, from which pluripotent stem cells are derived. Strategic application of histone agents, capable of altering epigenetic state such as methylation, allows zygotic activation and robust blastocyst generation.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: December 27, 2022
    Assignee: Sung Kwang Medical Foundation
    Inventors: Young Gie Chung, Dong Ryul Lee, Jin Hee Eum
  • Publication number: 20180208891
    Abstract: Provided are a storage method and a banking system of cells prepared using somatic cell nuclear transfer (NT) technology with homozygous genotypes of genes of human leukocyte antigen (HLA)-A, HLA-B, HLA-DR, and the like. The banking of NT cell-derived stem cells may be applied to autologous or allogenic patients and can provide transplantable cells and tissue materials for the treatment of various diseases such as diabetes, osteoarthritis, Parkinson's disease, and the like.
    Type: Application
    Filed: July 18, 2016
    Publication date: July 26, 2018
    Applicants: SUNGKWANG MEDICAL FOUNDATION, CHA BIOTECH CO., LTD.
    Inventors: Kwang Yul CHA, Dong Ryul LEE, Young Gie CHUNG, Jihwan SONG, Jin Hee EUM
  • Publication number: 20170204369
    Abstract: The present invention provides methods and compostions to improve the efficiency of somatic cell nuclear transfer (SCNT). There is increasing evidence that the epigenetic state of donor nuclei has a significant impact on potential of nuclear transfer embryos to develop into blastocysts, from which pluripotent stem cells are derived. Strategic application of histone agents, capable of altering epigenetic state such as methylation, allows zygotic activation and robust blastocyst generation.
    Type: Application
    Filed: October 28, 2016
    Publication date: July 20, 2017
    Applicant: Sung Kwang Medical Foundation
    Inventors: Young Gie Chung, Dong Ryul Lee, Jin Hee Eum